Healthcare Sales & Marketing Network News: AMMONUL

Searching News Database: AMMONUL

HSMN NewsFeed - 2 May 2013
Hyperion Therapeutics Exercises Option to Acquire Rights to BUPHENYL(R) and AMMONUL(R)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 18 Jun 2010
Medicis Announces Organizational Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Feb 2010
Medicis Receives Approval for RESTYLANE(R) and PERLANE(R) With Lidocaine
Devices Dermatology FDA

HSMN NewsFeed - 30 Apr 2009
FDA Approves Dysport(TM) for Therapeutic and Aesthetic Uses
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jun 2008
Medicis to Acquire LipoSonix
Devices Mergers & Acquisitions

HSMN NewsFeed - 4 Oct 2007
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Sep 2007
NEA Participates in $40M Investment in Hyperion Therapeutics
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 Sep 2007
Hyperion Therapeutics Secures $40 Million In Series B Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 21 May 2007
Medicis Begins Shipping PERLANE to Physicians
Biopharmaceuticals Dermatology

HSMN NewsFeed - 8 May 2006
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Biopharmaceuticals Dermatology FDA

Return to NewsFeed

Additional items found! 4

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 4 additional stories matching:
AMMONUL
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.